Liver Fibrosis
📧 Sign up to get email alerts when something new happens for Liver Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
This update reports on the FORCE trial evaluating FibroScan, a non-invasive liver fibrosis assessment tool, in pediatric cholestatic liver d…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Different Doses of ZED1227 vs. Placebo in NAFLD [Phase 2]
Phase 2 trial comparing different doses of ZED1227 to placebo in non-alcoholic fatty liver disease with liver fibrosis; the study has comple…
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Pirfenidone and Advanced Liver Fibrosis. [Phase 2]
Phase 2 trial update on pirfenidone for advanced liver fibrosis shows completion of the study.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis. [Phase 2]
Phase 2 trial comparing prolonged-release pirfenidone to placebo in compensated cirrhosis patients has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. [Phase 2]
Phase 2 study evaluating the efficacy, safety and tolerability of the combination of Tropifexor and Licogliflozin, as well as each monothera…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis [Phase 2]
Phase 2 trial of experimental medication BMS-986036 in adults with nonalcoholic steatohepatitis (NASH) and liver cirrhosis has completed wit…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis [Phase 1, Phase 2]
A terminated Phase 1/2 clinical trial evaluating probiotics for non-alcoholic fatty liver disease and steatohepatitis; results have been pos…
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis [Phase 2]
Phase 2 trial update of experimental medication BMS-986036 in adults with nonalcoholic steatohepatitis and stage 3 liver fibrosis; study com…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes [Phase 4]
Phase 4 trial exploring the effects of pioglitazone and evogliptin on hepatic fibrosis in patients with chronic hepatitis B and type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects [Phase 2]
Phase 2 trial update for CRV431 in NASH patients with F2-F3 fibrosis; study completed and results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis [Phase 2]
Phase II trial completed evaluating Hydronidone capsules (F351) for liver fibrosis due to chronic Hepatitis B infection.
-
CLINICAL_TRIALS trial_result · 2022-06-08Clinical Trial Update: Sildenafil for Liver Fibrosis in Adolescents and Adults After Fontan Operation [Phase 4]
Phase 4 clinical trial evaluating sildenafil for liver fibrosis in adolescents and adults after Fontan operation is underway, with status cu…
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C [Phase 2]
Phase 2 trial update for BMS-986263 in adults with advanced hepatic fibrosis after curing hepatitis C; study completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: Effect of Imatinib in Advance Liver Fibrosis Patients [Phase 1, Phase 2]
A clinical trial update on the effect of imatinib in patients with advanced liver fibrosis, currently in Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-11-12Clinical Trial Update: Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis [Phase 2]
Phase 2 study evaluating safety, tolerability, and efficacy of LJN452 combined with CVC in adult patients with non-alcoholic steatohepatitis…
-
CLINICAL_TRIALS trial_result · 2021-07-14Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH [Phase 2]
Phase 2 trial evaluating two doses of Aramchol versus placebo in non-alcoholic steatohepatitis (NASH) completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection [Phase 2]
Phase 2 clinical trial evaluating anticoagulation in liver fibrosis associated with hepatitis C; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis [Phase 2]
Phase 2 trial evaluating GR-MD-02 for safety and efficacy in liver fibrosis with portal hypertension due to NASH cirrhosis has completed wit…
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV [Phase 2]
Phase 2 trial of IDN-6556 in post-orthotopic liver transplant patients with chronic hepatitis C-related liver disease has completed with res…
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis [Phase 2]
Phase 2 study evaluating simtuzumab in adults with liver fibrosis and hepatitis C, including HIV co-infection; study completed with results …
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Impact of Transjugular Intrahepatic Portosystemic Shunts on Liver Stiffness [NA]
A terminated clinical trial evaluating transjugular intrahepatic portosystemic shunts (TIPS) and their impact on liver stiffness.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Shear Wave Sonoelastography in Pediatric Liver Fibrosis
A pediatric trial evaluating shear wave sonoelastography for assessing liver fibrosis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI) [Phase 4]
Phase 4 clinical trial updating on detecting liver fibrosis using MRI in chronic liver disease.
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: Effect of Some Drugs on Liver Fibrosis [Phase 3]
Phase 3 clinical trial assessing the effect of certain drugs on liver fibrosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Optimized Treatment and Regression of HBV-induced Liver Fibrosis [Phase 4]
A Phase 4 clinical trial completed that reports optimized treatment associated with regression of HBV-induced liver fibrosis.